Reports
Sale
Global Spatial Genomics and Transcriptomics Market Size: By Segmentation: Consumables, Instruments, Software, Services; By Application: Diagnostics and Disease Profiling, Drug Discovery, Others; By End Use; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis; Competitive Landscape; 2024-2032
Global Spatial Genomics and Transcriptomics Market Outlook
The global spatial genomics and transcriptomics market attained a value of USD 209.28 million in 2023. The industry is further expected to grow in the forecast period of 2024-2032 at a CAGR of 9.0% to reach USD 454.53 million in 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry is primarily being driven by the rising investments in the industry. North America is the largest regional market in the industry, whereas the Asia Pacific is expected to be the fastest-growing market in the forecast period.
Global Spatial Genomics and Transcriptomics Market Properties and Applications
Spatial genomics and transcriptomics allow researchers not only to see what is in a cell but also how cells are arranged in relation to each other to create invaluable insights into a disease. Spatial genomics and transcriptomics provide transcriptomic discovery and variety. It has various applications, particularly in molecular genetics.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry can be segmented into:
- Consumables
- Instruments
- Software
- Services
The industry can be broadly categorised based on its applications into:
- Diagnostics and Disease Profiling
- Drug Discovery
- Others
It finds its end-uses in the following sectors:
- Government Institutes and Academic Centres
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
The EMR report looks into the regional markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Spatial Genomics and Transcriptomics Market Analysis
The cumulative demand for robust diagnostic solutions for cancer, ongoing innovations in genetic devices, and the growing investments in genomics and transcriptomic studies are the key drivers of the industry growth. Emerging and start-up engineers are also working to address the growing demand for advanced technology to research spatial trends by introducing innovative products to their portfolio. The growing demand for biomarkers, which allow benign tumours to differentiate more accurately from malignant tumour, is increasing the demand for spatial genomic analysis as a diagnostic cancer tool.
The global spatial genomics and transcriptomics market is being driven by the rising awareness of disease management and drug discovery. The rapidly developing application segments in the market are disease management and drug discovery. The growth in genome awareness has resulted in increased research into a number of rare diseases in genetics and oncology. In addition, the increased demand for neurological and immunological diagnostics, as well as other biological fields, has significantly affected the industry growth.
Global Spatial Genomics and Transcriptomics Market Competitive Landscape
The report presents a detailed analysis of the following key players in the global spatial genomics and transcriptomics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- 10x Genomics
- Dovetail Genomics LLC
- Illumina, Inc.
- S2 Genomics, Inc.
- NanoString Technologies, Inc.
- Horizon Discovery Ltd.
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Segmentation |
|
| Breakup by Application |
|
| Breakup by End-Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Spatial Genomics and Transcriptomics Market Analysis
8.1 Key Industry Highlights
8.2 Global Spatial Genomics and Transcriptomics Historical Market (2018-2023)
8.3 Global Spatial Genomics and Transcriptomics Market Forecast (2024-2032)
8.4 Global Spatial Genomics and Transcriptomics Market by Segmentation
8.4.1 Consumables
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Instruments
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Software
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.4.4 Services
8.4.4.1 Historical Trend (2018-2023)
8.4.4.2 Forecast Trend (2024-2032)
8.5 Global Spatial Genomics and Transcriptomics Market by Application
8.5.1 Diagnostics and Disease Profiling
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Drug Discovery
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Others
8.6 Global Spatial Genomics and Transcriptomics Market by End-Use
8.6.1 Government Institutes and Academic Centres
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Pharmaceutical and Biotechnology Companies
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Contract Research Organizations (CROs)
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.7 Global Spatial Genomics and Transcriptomics Market by Region
8.7.1 North America
8.7.2 Europe
8.7.3 Asia Pacific
8.7.4 Latin America
8.7.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2023)
9.3.2 Forecast Trend (2024-2032)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2023)
9.4.2 Forecast Trend (2024-2032)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2023)
9.5.2 Forecast Trend (2024-2032)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 10x Genomics
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Dovetail Genomics LLC
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Illumina, Inc.
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 S2 Genomics, Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 NanoString Technologies, Inc.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Horizon Discovery Ltd.
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 Others
13 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Spatial Genomics and Transcriptomics Market: Key Industry Highlights, 2018 and 2032
2. Global Spatial Genomics and Transcriptomics Historical Market: Breakup by Segmentation (USD Million), 2018-2023
3. Global Spatial Genomics and Transcriptomics Market Forecast: Breakup by Segmentation (USD Million), 2024-2032
4. Global Spatial Genomics and Transcriptomics Historical Market: Breakup by Application (USD Million), 2018-2023
5. Global Spatial Genomics and Transcriptomics Market Forecast: Breakup by Application (USD Million), 2024-2032
6. Global Spatial Genomics and Transcriptomics Historical Market: Breakup by End-Use (USD Million), 2018-2023
7. Global Spatial Genomics and Transcriptomics Market Forecast: Breakup by End-Use (USD Million), 2024-2032
8. Global Spatial Genomics and Transcriptomics Historical Market: Breakup by Region (USD Million), 2018-2023
9. Global Spatial Genomics and Transcriptomics Market Forecast: Breakup by Region (USD Million), 2024-2032
10. North America Spatial Genomics and Transcriptomics Historical Market: Breakup by Country (USD Million), 2018-2023
11. North America Spatial Genomics and Transcriptomics Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Europe Spatial Genomics and Transcriptomics Historical Market: Breakup by Country (USD Million), 2018-2023
13. Europe Spatial Genomics and Transcriptomics Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Asia Pacific Spatial Genomics and Transcriptomics Historical Market: Breakup by Country (USD Million), 2018-2023
15. Asia Pacific Spatial Genomics and Transcriptomics Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Latin America Spatial Genomics and Transcriptomics Historical Market: Breakup by Country (USD Million), 2018-2023
17. Latin America Spatial Genomics and Transcriptomics Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Middle East and Africa Spatial Genomics and Transcriptomics Historical Market: Breakup by Country (USD Million), 2018-2023
19. Middle East and Africa Spatial Genomics and Transcriptomics Market Forecast: Breakup by Country (USD Million), 2024-2032
20. Global Spatial Genomics and Transcriptomics Market Structure
Key Questions Answered in the Report
In 2023, the global spatial genomics and transcriptomics market attained a value of nearly USD 209.28 million.
The market is projected to grow at a CAGR of 9% between 2024 and 2032.
The industry is being propelled by the increased investments, increasing consciousness of disease management and drug discovery, growing need for neurological and immunological diagnostics, and growing demand for biomarkers.
The key trends augmenting the industry’s expansion are the rising need for effective cancer diagnostic solutions and increased funding in genomics and transcriptome studies.
The major regions in the industry are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific with North America accounting for the largest share in the market.
The industry can be segmented into consumables, instruments, software, and services.
The disease management and drug discovery segments are the dominant applications in the industry.
The end-uses include government institutes and academic centres, pharmaceutical and biotechnology companies, and contract research organisations (CROs).
The major players in the industry are 10x Genomics, Dovetail Genomics LLC, Illumina, Inc., S2 Genomics, Inc., NanoString Technologies, Inc., and Horizon Discovery Ltd., among others.
Analyst Review
The global spatial genomics and transcriptomics market attained a value of USD 209.28 million in 2023, driven by the growing need for neurological and immunological diagnostics. Aided by the rising need for effective cancer diagnostic solutions and increased funding in genomics and transcriptome studies, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 9%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its segmentation, the global spatial genomics and transcriptomics industry can be divided into consumables, instruments, software, and services. By application, the industry can be segmented into diagnostics and disease profiling and drug discovery, among others. On the basis of end-use, government institutes and academic centres, pharmaceutical and biotechnology companies, and contract research organisations (CROs) are the major categories. The major regional markets for spatial genomics and transcriptomics are North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific, with North America accounting for the largest share of the market. The key players in the above market include 10x Genomics, Dovetail Genomics LLC, Illumina, Inc., S2 Genomics, Inc., NanoString Technologies, Inc., and Horizon Discovery Ltd., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER